leucine has been researched along with Tauopathies in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ceballos, C; Dickson, DW; Hyman, BT; Lin, WL; Polydoro, M; Ren, Y; Sahara, N; Sanchez, L; Spires-Jones, TL | 1 |
| Cattepoel, S; Eckert, A; Kuehnle, K; Kulic, L; Nitsch, RM; Pagani, L; Rhein, V; Tracy, J; Wollmer, MA | 1 |
| Bista, P; Götz, J; Köhler, C; Schröder, H | 1 |
| Adamowicz, DH; Carlson, GA; Fox, LM; Hyman, BT; Pitstick, R; Spires-Jones, TL; William, CM | 1 |
| Chen, A; Diaz-Ruiz, C; Ho, L; Ksiezak-Reding, H; Pasinetti, GM; Santa-Maria, I; Wang, J | 1 |
| Britschgi, M; Johns, H; Masliah, E; Rockenstein, E; Takeda-Uchimura, Y; Wyss-Coray, T | 1 |
| Baker, M; Berry, RW; Bigio, EH; Binder, LI; Davies, P; de Silva, R; Demirci, S; Dickson, D; Espinoza, M; Gamblin, TC; Grover, A; Grujic, ZM; Guillozet, AL; Herzog, LL; Hogg, M; Hutton, M; Ishizawa, T; LaPointe, NE; Lees, A; Mesulam, MM; Sahara, N; Sweet, AP; Weintraub, S; Yen, SH | 1 |
| George-Hyslop, PS; Hagiwara, H; Ikeda, M; Kawarabayashi, T; Matsubara, E; Murakami, T; Nakazato, Y; Sasaki, A; Shoji, M; Westaway, D | 1 |
8 other study(ies) available for leucine and Tauopathies
| Article | Year |
|---|---|
Endogenous tau aggregates in oligodendrocytes of rTg4510 mice induced by human P301L tau.
Topics: Analysis of Variance; Animals; Antibodies; Brain; Disease Models, Animal; Gene Expression Regulation; Humans; Leucine; Mice; Mice, Transgenic; Microscopy, Immunoelectron; Molecular Weight; Mutation; Oligodendroglia; Proline; Rats; tau Proteins; Tauopathies | 2014 |
Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration.
Topics: Adenosine Triphosphate; Age Factors; Animals; Apoptosis; Apoptosis Inducing Factor; Brain; Caspase 3; Electron Transport Complex I; Gene Expression Regulation; Genetic Predisposition to Disease; Humans; In Situ Nick-End Labeling; Leucine; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mice, Transgenic; Mitochondria; Mitochondrial Diseases; Movement Disorders; Mutation; Nerve Degeneration; Nerve Tissue Proteins; Oxidative Stress; Proline; Proton Pumps; Silver Staining; Statistics, Nonparametric; tau Proteins; Tauopathies | 2011 |
Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy.
Topics: Animals; Basigin; Brain; Choline O-Acetyltransferase; Cholinergic Agents; Gene Expression Regulation; Interneurons; Leucine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Proline; tau Proteins; Tauopathies | 2010 |
Soluble tau species, not neurofibrillary aggregates, disrupt neural system integration in a tau transgenic model.
Topics: Animals; Animals, Genetically Modified; Cell Count; Cytoskeletal Proteins; Disease Models, Animal; Doxycycline; Environment; Gene Expression Regulation; Hippocampus; Indoles; Leucine; Mice; Mutation; Nerve Tissue Proteins; Neurofibrillary Tangles; Neurons; Proline; RNA, Messenger; tau Proteins; Tauopathies | 2011 |
GSPE interferes with tau aggregation in vivo: implication for treating tauopathy.
Topics: Analysis of Variance; Animals; Antioxidants; Brain; Disease Models, Animal; Grape Seed Extract; Humans; Leucine; Male; Mice; Mice, Transgenic; Molecular Weight; Mutation; Polyphenols; Proline; Psychomotor Performance; Spinal Cord; tau Proteins; Tauopathies | 2012 |
Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice.
Topics: Animals; Brain; CD59 Antigens; Disease Models, Animal; Green Fluorescent Proteins; Humans; Leucine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Nerve Tissue Proteins; Neurodegenerative Diseases; Neurons; Phosphorylation; Proline; Receptors, Complement; Signal Transduction; tau Proteins; Tauopathies | 2012 |
The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy.
Topics: Adult; Antibodies, Monoclonal; Blotting, Western; Brain; Dementia; DNA Mutational Analysis; Exons; Family Health; Humans; Immunohistochemistry; In Vitro Techniques; Leucine; Male; Microscopy, Electron; Microtubules; Mutation; Pick Disease of the Brain; Protein Isoforms; Receptors, Endothelin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; tau Proteins; Tauopathies; Time Factors; Valine | 2003 |
Microglial activation in brain lesions with tau deposits: comparison of human tauopathies and tau transgenic mice TgTauP301L.
Topics: Age Factors; Aged; Aged, 80 and over; Animals; Brain; Calcium-Binding Proteins; DNA-Binding Proteins; Female; Histocompatibility Antigens Class II; Humans; Leucine; Male; Mice; Mice, Transgenic; Microfilament Proteins; Microglia; Microscopy, Electron, Transmission; Middle Aged; Mutation; Proline; Receptors, Scavenger; tau Proteins; Tauopathies | 2008 |